Alpha Teknova (TKNO) Competitors

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends.

Does the MarketBeat Community believe in CALT or TKNO?

Calliditas Therapeutics AB (publ) received 18 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 55.10% of users gave Calliditas Therapeutics AB (publ) an outperform vote while only 39.13% of users gave Alpha Teknova an outperform vote.

Company	Underperform	Outperform
Calliditas Therapeutics AB (publ)	Outperform Votes 27 55.10%	Underperform Votes 22 44.90%
Alpha Teknova	Outperform Votes 9 39.13%	Underperform Votes 14 60.87%

Is CALT or TKNO more profitable?

Calliditas Therapeutics AB (publ) has a net margin of -30.18% compared to Alpha Teknova's net margin of -87.17%. Alpha Teknova's return on equity of -35.30% beat Calliditas Therapeutics AB (publ)'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Calliditas Therapeutics AB (publ)	-30.18%	-212.04%	-27.96%
Alpha Teknova	-87.17%	-35.30%	-24.52%

Which has more volatility & risk, CALT or TKNO?

Calliditas Therapeutics AB (publ) has a beta of 1.77, indicating that its stock price is 77% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Do analysts rate CALT or TKNO?

Calliditas Therapeutics AB (publ) currently has a consensus target price of $39.25, suggesting a potential downside of 1.88%. Alpha Teknova has a consensus target price of $8.50, suggesting a potential upside of 54.83%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Calliditas Therapeutics AB (publ).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Calliditas Therapeutics AB (publ)	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Alpha Teknova	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer CALT or TKNO?

In the previous week, Alpha Teknova had 4 more articles in the media than Calliditas Therapeutics AB (publ). MarketBeat recorded 4 mentions for Alpha Teknova and 0 mentions for Calliditas Therapeutics AB (publ). Calliditas Therapeutics AB (publ)'s average media sentiment score of 0.00 equaled Alpha Teknova'saverage media sentiment score.

Company	Overall Sentiment
Calliditas Therapeutics AB (publ)	Neutral
Alpha Teknova	Neutral

Do institutionals and insiders believe in CALT or TKNO?

2.8% of Calliditas Therapeutics AB (publ) shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 2.2% of Calliditas Therapeutics AB (publ) shares are owned by company insiders. Comparatively, 15.2% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has stronger valuation & earnings, CALT or TKNO?

Alpha Teknova has lower revenue, but higher earnings than Calliditas Therapeutics AB (publ). Calliditas Therapeutics AB (publ) is trading at a lower price-to-earnings ratio than Alpha Teknova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Calliditas Therapeutics AB (publ)	$1.60B	0.74	-$43.96M	-$1.85	-21.62
Alpha Teknova	$37.75M	7.77	-$36.78M	-$0.59	-9.31

Summary

Alpha Teknova beats Calliditas Therapeutics AB (publ) on 12 of the 17 factors compared between the two stocks.